3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
7
Small Cell Lung Carcinoma
6
Fallopian Tube Neoplasms
4
Lung Neoplasms
3
Neoplasm Metastasis
2
Ganglioneuroblastoma
2
Uterine Cervical Neoplasms
1
Sarcoma, Ewing
1
SCLC
1
Rhabdoid Tumor
1
Peritoneal Neoplasms
1
Pediatric Brain Tumor
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Fallopian Tube Mucinous Adenocarcinoma
1
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
1
Choroid Plexus Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Neuroendocrine
1
Interventions
venetoclax
29
Cytarabine
26
Azacitidine
26
Specimen Handling
23
fludarabine
17
Biopsy
15
Cyclophosphamide
14
Injections
13
fludarabine phosphate
11
Daunorubicin
11
Whole-Body Irradiation
10
CPX-351
9
decitabine and cedazuridine drug combination
8
ivosidenib
7
Mycophenolic Acid
7
Tacrolimus
6
Melphalan
6
Idarubicin
6
Granulocyte Colony-Stimulating Factor
6
Gemtuzumab
6
Filgrastim
6
Decitabine
6
Busulfan
6
enasidenib
5
X-Rays
5
Peripheral Blood Stem Cell Transplantation
5
Magnetic Resonance Spectroscopy
5
Etoposide
5
Cyclosporine
5
ruxolitinib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid, Acute
×
Topotecan
×
30 days
×
Clear all
No trials found.